Tocqueville Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-171,290	Closed	-$2.85M	–	688
2022 Q1	$2.85M	Buy	171,290 +30,350	+22%	+$469K	0.04%	306
2021 Q4	$2.69M	Sell	140,940 -8,400	-6%	-$185K	0.04%	343
2021 Q3	$3.68M	Sell	149,340 -12,750	-8%	-$300K	0.05%	290
2021 Q2	$4.22M	Buy	162,090 +68,500	+73%	+$1.78M	0.06%	280
2021 Q1	$2.96M	Sell	93,590 -1,860	-2%	-$77.1K	0.05%	321
2020 Q4	$4.43M	Buy	95,450 +60,450	+173%	+$2.4M	0.07%	247
2020 Q3	$1.15M	Hold	35,000	–	–	0.02%	384
2020 Q2	$961K	Hold	35,000	–	–	0.02%	396
2020 Q1	$1.05M	Sell	35,000 -25,000	-42%	-$663K	0.03%	349
2019 Q4	$1.66M	Sell	60,000 -68,605	-53%	-$1.56M	0.02%	377
2019 Q3	$2.34M	Buy	128,605 +1,550	+1%	+$34.3K	0.03%	357
2019 Q2	$3.12M	Buy	127,055 +82,930	+188%	+$1.25M	0.04%	347
2019 Q1	$420K	Buy	44,125 +17,300	+64%	+$168K	0.01%	618
2018 Q4	$237K	Buy	26,825 +3,000	+13%	+$28.9K	﹤0.01%	669
2018 Q3	$268K	Sell	23,825 -1,100	-4%	-$15.6K	﹤0.01%	712
2018 Q2	$319K	Buy	24,925 +14,100	+130%	+$206K	﹤0.01%	680
2018 Q1	$183K	Buy	+10,825	New	+$164K	﹤0.01%	795
2017 Q2	–	Sell	-23,000	Closed	-$171K	–	814
2017 Q1	$171K	Hold	23,000	–	–	﹤0.01%	767
2016 Q4	$160K	Hold	23,000	–	–	﹤0.01%	769
2016 Q3	$189K	Buy	+23,000	New	+$195K	﹤0.01%	784